Journals / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 4

Prediction of Response to Neoadjuvant Chemoradiotherapy with Machine Learning in Rectal Cancer: A Pilot Study

Pages
459–467
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Artificial intelligence; machine learning; neoadjuvant chemoradiotherapy; prediction of treatment response; rectal cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE In locally advanced rectal cancer, trimodality therapy comprising chemoradiotherapy, total mesorectal excision, and chemotherapy (CT) are accepted as standard treatment.
📊
Key Findings & Data:In cases with a good response, less invasive surgical treatments, such as sphincter-sparing local excision or the watch-andwait approach may be more appropriate due to their lower recurrence rates.
💡
Conclusion & Impact:Keywords: Artificial intelligence; machine learning; neoadjuvant chemoradiotherapy; prediction of treatment response; rectal cancer.
🔬Design:Modeling & Simulation
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE In locally advanced rectal cancer, trimodality therapy comprising chemoradiotherapy, total mesorectal excision, and chemotherapy (CT) are accepted as standard treatment. However, standard “one-size-fitsall” therapy based on the TNM staging system may not be suitable for every patient. In cases with a good response, less invasive surgical treatments, such as sphincter-sparing local excision or the watch-andwait approach may be more appropriate due to their lower recurrence rates. Therefore, it is very important to predict these cases and plan treatment accordingly to ensure effective personalized treatment. Machine learning can successfully predict these cases. Aim: The aim of the study was to predict the response to neoadjuvant chemoradiotherapy with machine learning in locally advanced rectal cancer. METHODS The study included 125 rectal cancer cases who underwent neoadjuvant radiotherapy (RT)±CT between 2010 and 2020, and the cases with a good response (grade 0-1) according to the Modified Ryan classification were predicted using machine learning. A total of 26 variables were evaluated. After determining key variables, the dataset was divided into training/test sets at 80%/20%. Logistic regression, artificial neural network-multilayer perceptron classifier, XGBoost, support vector classification, random forest, and Gaussian Naive Bayes algorithms used to establish a prediction model. In the prediction of the group with a good response, 173 cases were created and evaluated with the synthetic minority oversampling technique method. RESULTS Of the 125 cases, 15 had a complete response and 33 had a good response (Modified Ryan grades 0 and 1). Six algorithms were tested in terms of their ability to predict a good response. Key variables for this prediction were found to be tumor localization, RT break time, age, gender, Karnofsky Performance Scale score, body mass index, pre- and post-treatment carcinoembryonic antigen levels, pre-treatment hemoglobin and neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio, radiological T and N stages, perineural and lymphatic invasion, tumor grade, radiological metastatic lymph node region, RT dose and technique, and presence and scheme of concurrent CT. The algorithm that showed the best performance was determined as logistic regression with an accuracy rate of 84% (CI: 0.69-0.98), sensitivity of 83%, and specificity of 85%. CONCLUSION It is very important to predict the cases with a good response and plan treatment accordingly to ensure effective personalized treatment. Machine learning can successfully predict these cases. Keywords: Artificial intelligence; machine learning; neoadjuvant chemoradiotherapy; prediction of treatment response; rectal cancer.

🔖

Cite This Article

ÇELİK, Ö., BADAK, B., ÖZEN, A., YILMAZ, E., YAKAR, M., ETİZ, D., KÜTRİ, D. (2022). Prediction of Response to Neoadjuvant Chemoradiotherapy with Machine Learning in Rectal Cancer: A Pilot Study. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 4, 459–467. https://ajindex.com/articles/639098

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. National Comprehensive Cancer Network. NCCN Guidelines. Rectal Cancer, Version 1. Available at: National Comprehensive Cancer Network; 2021. Available from: http://www.nccn.org. Accessed Sep 1, 2021
  2. Meyer P, Noblet V, Mazzara C, Lallement A. Survey on deep learning for radiotherapy. Comput Biol Med 2018;98:126–46
  3. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015;521(7553):436–44
  4. Jarrett D, Stride E, Vallis K, Gooding MJ. Applications and limitations of machine learning in radiation oncology. Br J Radiol 2019;92(1100):20190001
  5. Bibault JE, Giraud P, Burgun A. Big data and machine learning in radiation oncology: State of the art and future prospects. Cancer Lett 2016;382(1):110–7
  6. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30(16):1926–33
  7. Gérard JP, Azria D, Gourgou-Bourgade S, MartelLaffay I, Hennequin C, Etienne PL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-prodige 2. J Clin Oncol 2010;28(10):1638–44
  8. Borschitz T, Wachtlin D, Möhler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008;15(3):712–20
  9. Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): A propensity-score matched cohort analysis. Lancet Oncol 2016;17(2):174–83. 10.Ludwig KA. Sphincter-sparing resection for rectal cancer. Clin Colon Rectal Surg 2007;20(3):203–12. 11.Marijnen CA. Organ preservation in rectal cancer: Have all questions been answered? Lancet Oncol 2015;16(1):e13–22. 12.Weiser MR. AJCC 8th edition: Colorectal cancer. Ann Surg Oncol 2018;25(6):1454–5. 13.Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47(2):141–6. 14.Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. New York: Springer; 2009. 15.Chen T, Guestrin C. Xgboost: A Scalable Tree Boosting System. In: KDD 16: Proceedings o